A.P. Pharma

A.P. Pharma, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments utilizing its proprietary polymer-based drug delivery systems.

The Company's primary emphasis is on advancing its Biochronomer™ technology platform for site-specific and systemic drug delivery. Designed to release drugs over a period of hours, days, weeks or even months, Biochronomer systems can be fabricated into a wide range of solid and free-flowing gel forms which erode away as they deliver the drug. A variety of injectable and implantable applications are undergoing feasibility testing to address major unmet needs in pain management, inflammation, oncology, ophthalmology and other medical fields.



The Company's current product development programs are funded by royalties from topical prescription products marketed by pharmaceutical partners and proceeds from the divestiture of its cosmeceutical product lines.

Contact Details: 123 Saginaw Drive Redwood City CA 94062 United States of America Tel: 650-366-2626 Fax: Email: busdev@appharma.com

Loading...

Recent Publications by A.P. Pharma:
Post surgical pain management with poly(ortho esters). Poly(ortho esters), POE, are synthetic bioerodible polymers that can be...	22nd April, 2003	A.P. Pharma, 123 Saginaw Drive, Redwood City, CA 94063, USA.	Adv Drug Deliv Rev. 2002 Oct 16;54(7):1041-8.
Poly(ortho esters): synthesis, characterization, properties and uses. Over the last 30 years, poly(ortho esters) have evolved through four...	22nd April, 2003	A.P. Pharma, 123 Saginaw Drive, Redwood City, CA 94063, USA.	Adv Drug Deliv Rev. 2002 Oct 16;54(7):1015-39.

BioNews Results for A.P. Pharma:
Archimedes to Lead ,2.77 Million EU Programme to Develop Intranasal Avian Influenza Vaccine	Pharma Live:  Jul 20 2008 4:08AM Matching: pharma
Drug-testing firm MDS cutting jobs, profits	Chronicle Herald:  Jul 19 2008 11:07AM Matching: pharma
BioAlliance Pharma suspends phase II trial of doxorubicin Transdrug	PharmaBiz:  Jul 19 2008 9:00AM Matching: pharma
Riemser Buys Rentschler Pharma	Chemical Week:  Jul 19 2008 1:17AM Matching: pharma
MDS takes charges to bolster competitive edge	Clinical Lab Products:  Jul 19 2008 5:17PM Matching: pharma
Promote your company here: BioNewsCast - Press Release Distribution	→View more A.P. Pharma news.

A.P. Pharma Patents:
US Patent No.	Title
7220414	Degradable polyacetal polymers
7163694	Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
7045589	Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
6946145	Block copolymers based on poly(ortho esters) containing amine groups
6863782	Method of preparing di(ketene acetals)
→View more A.P. Pharma patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 628 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: 123 saginaw dr redwood city ca 94063 650 366 2626 | AP PHARMA | BLOCK COPOLYMERS COMPANY PHARMA | AP Pharma POE IV | AP Pharma | AP Pharma USA | ap usa pharmaceuticals | AP Pharma POE | a.p.pharmaCAUSA | a.p.pharmaCAUSA | .

Search for more companies in Redwood City

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for A.P. Pharma